Global Genetic Testing Market For Prenatal and New-born Will Reach USD 8.37 Billion in 2019

A new market report published “Prenatal and Newborn Genetic Testing Market (PCR, FISH, aCGH, NIPT and MSS): Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019″ the global prenatal and newborn genetic testing market was valued USD 1.12 billion in 2012 and expected to grow at a CAGR of 26.9% from 2013 to 2019, to reach an estimated value of USD 8.37 billion in 2019. Prenatal and newborn genetic testing is referred to the utilization of screening/diagnostic procedures for a fetus or a new born baby to detect chromosomal abnormalities such as Down syndrome, Patau syndrome and Edward syndrome.

These testing procedures enable detection of certain genetic abnormalities in as early as 8 to 10 weeks of gestation and also help to determine the sex of the fetus. According to Northwestern Medical Faculty Foundation, Down syndrome, open neural tube defects and trisomy 18 are the birth defects that 85% of women are advised to be screened or tested during pregnancy. Whereas, there are some tests which provides information about trisomy 13 and other chromosome abnormalities. Prenatal and newborn genetic tests are of two types, diagnostic and screening tests. Diagnostic tests helps to confirm the presence of certain genetic conditions in a fetus or a new born baby, while screening tests detects the chance of development of certain genetic abnormalities in a fetus or new born baby.


Browse Global Prenatal and Newborn Genetic Testing Market Report with Full TOC at http://www.transparencymarketresearch.com/prenatal-new-born-genetic-testing.html


The prenatal and newborn genetic testing market is driven by increasing maternal age and late pregnancies, technological Transparency Market Researchadvancements and growing awareness about genetic disorders in the fetus. It was also observed that the prenatal and newborn genetic testing market is still at a nascent stage and have many opportunities such as capitalizing on potential markets in the emerging Asian, African and Latin American countries. In diagnostic techniques market, polymerase chain reaction (PCR) segment accounted for the largest share, as compared to FISH and aCGH. The PCR market is mainly driven by rising incidences of genetic diseases and forensics coupled with high process efficiency, better precision and reliability of the technique, and amplification.


Non-invasive prenatal testing (NIPT) is the largest market segment in screening method and is expected to grow at highest CAGR of 37.6% from 2013 to 2019. The North American region accounted for the largest share of the total prenatal and newborn genetic testing market. One of the key factors driving the growth of North America market is the non-invasive nature of the test that completely eliminates the risk of miscarriage associated with invasive tests such as amniocentesis and CVS (Chorionic Villus Sampling).


The diagnostic testing techniques market consists of key players such as Bio-Rad Laboratories, Agilent Technologies, Perkin Elmer and Ariosa Diagnostics. Agilent Technologies and Bio-Rad Laboratories are the leading players in diagnostic testing techniques market because of their dominance in reagents and instruments market. Major players of the screening methods market are Sequenom, Inc., Illumina, Inc. and Natera, Inc.


Overall Sequenom, Inc. and Verinata Health are the major market players of the global prenatal and newborn genetic testing market because of their initial product launches in this market. The global prenatal and newborn genetic testing market is segmented as follows:


Prenatal and Newborn Genetic Testing Market, by Technology

Diagnostic Techniques
Polymerase Chain Reaction (PCR)

Fluorescence In-Situ Hybridization (FISH)

Array-Comparative Genomic Hybridization (aCGH)

Screening Methods
Non-invasive Prenatal Tests (MaterniT21 PLUS, Verifi, Harmony, Panorama, NIFTY, PrenaTest and Bambni Test)

Maternal Serum Screening (MSS)

Prenatal and Newborn Genetic TestingMarket, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1744


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.


Contact:
Mr.Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com/

Immunoprotein Diagnostic Testing Market is Expected to Reach USD 15.4 Billion Globally in 2019

According to a new market report published by Transparency Market Research "Immunoprotein Diagnostic Testing Market (Radioimmunoassay, Enzyme Based Immunoassay, Chemiluminescence Assay, Immunofluorescence Assay, Immunoturbidity Assay and Immunoprotein Electrophoresis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019," the global immunoprotein diagnostic testing market was valued at USD 11.1 billion in 2012 and is expected to grow at a CAGR of 5.7% from 2013 to 2019, to reach an estimated value of USD 15.4 billion in 2019.

Browse Immunoprotein Diagnostic Testing Market Report With Full TOC at http://www.transparencymarketresearch.com/immunoprotein-diagnostic-testing.html

Immunoproteins play a vital role in launching an immune response against an antigen. These immunoproteins show a minimal serum level under normal conditions, but on exposure to antigen, their levels increase 10 to 100 fold within 24 to 48 hours. This characteristic property of immunoproteins has been exploited in the field of disease diagnosis and has now become an integral part of the healthcare sector. With the rising incidences of diseases such as cancer, diabetes, tuberculosis, malaria, and various viral infections, quick and confirmed diagnosis has become a prime need in hospitals and diagnostic centers worldwide. The aging of population has added to the number of individuals seeking medical attention and is expected to continue rising in the future. Moreover, the prevalence of allergies and autoimmune diseases whose diagnosis is even more critical is also on the rise. The collective effect of these incidences will propel the immunoprotein diagnostic testing market to grow at a CAGR of 5.7% from 2013 to 2019.

The immunoprotein diagnostic testing market has been segmented on the basis of technology into radioimmunoassay, enzyme based immunoassay, chemiluminescence assay, immunofluorescence assay, immunoturbidity assay, and immunoprotein electrophoresis. The enzyme based immunoassay segment which includes enzyme linked immunosorbent assay (ELISA) and multiplex ELISA, covers the maximum market share owing to the longstanding ELISA market. Other market segments such as chemiluminescence face challenges particularly since end users do not wish to replace already existing fully functional ELISA technology. Expensive instruments and reluctance of laboratory workers to upgrade their knowledge and technology has added to the woes of this market. But, with obsolescence of installed base and demand for better diagnostic services, the market for traditional ELISA is expected to shrink. Chemiluminescence assays are becoming increasingly popular as they are similar to ELISA; multiplex chemiluminescence assays have also become popular in the diagnostic industry.

Growing knowhow about various cancer biomarkers coupled with innovation in biotechnology has made cancer testing easier and more accurate. Application of multiplex ELISA in cancer diagnosis has enabled simultaneous analysis of multiple biomarkers. Free Light Chain (FLC) assays by The Binding Site have been widely used in diagnosis and monitoring of patients with multiple myeloma. Enzyme multiplied immunoassay technique (EMIT) patented technology by Siemens Healthcare Diagnostics is used for toxicology testing. ImmunoCAP by Phadia, a Thermo Fisher Scientific company, has been a standard in allergy testing. Various such assay technologies have contributed in making the diagnostics market dynamic and growing.

Geographically, North America lead the market in 2012, while Asia-Pacific and Rest of the World (which comprises Africa, Middle East and Latin America) are anticipated to be the most attractive markets in the near future. Rising per capita income, increasing awareness about available medical services, and medical tourism has boosted the market growth in these nations.

The global immunoprotein diagnostic testing market is segmented as follows:

Immunoprotein Diagnostic Testing Market, by Technology

Radioimmunoassay

Enzyme based immunoassay

Chemiluminescence assay

Immunofluorescence assay

Immunoturbidity assay

Immunoprotein electrophoresis

Immunoprotein Diagnostic Testing Market, by Immunoprotein Type

Complement system protein diagnostic tests

Free Light Chain diagnostic tests

Haptoglobin diagnostic tests

Immunoglobulin diagnostic tests

Prealbumin diagnostic tests

C-reactive protein diagnostic tests

Request a Sample of this : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1253

Immunoprotein Diagnostic Testing Market, by Application

Infectious Disease Testing

Oncology Testing

Endocrine Testing

Toxicology Testing

Allergy Testing

Autoimmune testing

Immunoprotein Diagnostic Testing Market, by Geography

North America

Europe

Asia-Pacific

Rest of the World (RoW)

Browse Biotechnology Market Reports at http://www.transparencymarketresearch.com/biotechnology-market-reports-18.html

About Us:

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Global Agricultural Biotechnology Market is Expected to Reach USD 28,694.1 Million in 2019

According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) “Agricultural Biotechnology Market For Transgenic Crops (Corn, Soybean, Cotton and Others), Synthetic Biology-Enabled Products and Tools – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,”the global agricultural biotechnology market was valued at USD 15,300 million in 2012 and is expected to reach USD 28,694.1 million by 2019, growing at a CAGR of 9.5% from 2013 to 2019.



Demand for food production has increased significantly due to rise in global population. This is one of the major drivers for growth in the agricultural biotechnology market. Furthermore, growing demand for biofuels due to depleting conventional resources is further boosting the global agricultural biotechnology market. However, strong opposition of GM crops in Europe is estimated to hamper market growth.



global-agricultural-biotechnology-market-revenue-share-by-geography-2012-and-2019
The global agricultural biotechnology market was dominated by North America due to high cultivation of GM crops and acceptance of these crops by consumers. North America accounted for 32.5% of the market share in 2012. Europe consumes substantial amount of GM crops for animal feed, which is imported from Brazil and the U.S. However, there is hardly any production of GM crops in Europe due to stringent regulations and strong opposition from consumers. Asia Pacific market is projected to reach USD 7,810.5 million by 2019. Growth in demand for food in Asia coupled with rapid growth in industrialization is expected to boost the agricultural biotechnology market in Asia Pacific. Large scale production of transgenic crops is expected to drive the RoW market during the forecast period.



Transgenic crops or GM crops emerged as the largest application of the agricultural biotechnology market. Rising demand for food production coupled with decrease in arable land is anticipated to drive the transgenic crops application. The global agricultural biotechnology market for transgenic crops is anticipated to grow at a CAGR of 9.6% from 2013 to 2019. Synthetic biology-enabled products and tools accounted for smaller share of the market in 2012.



Soybean and corn are the most widely consumed GM crops globally. Rising demand for animal feed due to increasing consumption of meat is expected to drive the market for these crops. The market for transgenic corn is expected to grow at a CAGR of 9.6% from 2013 to 2019. Other crops which mainly includes rapeseed, potato, alfalfa and sugar beet accounted for 10.9% revenue share in 2012.



The overall agricultural market is consolidated as top three players accounted for nearly 48% of the market in 2012. Key industry participants include Monsanto, DuPont Pioneer Hi-Bred, Syngenta, Dow AgroSciences, Vilmorin, Bayer CropScience, Certis USA, Evogene Ltd, and KWS SAAT AG among others.



Browse the full report at http://www.transparencymarketresearch.com/agricultural-biotechnology-market.html



This report segments the global agricultural biotechnology market as follows:
Agricultural Biotechnology Market: Application Analysis
Transgenic crops
Corn
Soybean
Cotton
Others
Synthetic biology-enabled products
Tools
Agricultural Biotechnology Market: Regional Analysis
North America
Europe
Asia Pacific
Rest of the World



Request a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=598




About Us

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.



Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.



Contact:
Mr.Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Life Science Reagents Market Expected to Reach USD 25.7 Billion Globally in 2019

According to a new market report published by Transparency Market Research (www.transparencymarketresearch.com) “Life Science Reagents Market (Products- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis, Chromatography, In-Vitro Diagnostic Reagents and Others; End Users- Commercial and Contract Manufacturers, Research and Academic Institutions, Clinical Laboratories, and Forensic Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019”, the global life science reagents market was valued at USD 12.44 billionin 2012and is expected to grow at a CAGR of 10.8%from 2013 to 2019, to reach an estimated value of USD 25.73billion in 2019.



Being predominantly used in a wide range of analytical and manufacturing processes,reagents areone of the fastest moving and widely consumed products in the life science industry. Factors such as rise in the number of government initiatives for the growth of biotechnology industry and advancement in related technologies will have a tremendous impact on the growth of the life science reagents market.



Amongst the various typesof commercially available life science reagents, chromatography and in-vitro diagnostic reagents were the largest product segments in 2012, with a cumulative market share of more than 50% in the overall life science reagents market. In addition, the polymerase chain reaction (PCR) reagent kits market is expected to cannibalizethe market share of other product segments during the forecast perioddue to expansion of its application area from only commercial manufacturing to in-vitro diagnostics.It is expected that the global market for polymerase chain reaction (PCR) reagent kits will reach USD 4.26billion in 2019 growing at a CAGR of 14.2%from 2013 to 2019.



Research and academic institutes from the largest set of consumers, by revenue, of life science reagents. Growth in research and development activities by biotechnology companies with an intention to introduce breakthrough technologies in the market has led to rise in consumption of life science reagents in related processes.



Geographically, North America dominated the global life science reagents marketin 2012 mainly due to the advantage of bigger patent repositorywith biotechnology companies based in this region.Factors that will drive future growthof the North American life science reagents market include existence of supportive economic base, highly developed research infrastructure, technological advancement and higher adoption rate of those technologies.



However,countries in the Asia-Pacificregion such as China, Japan and India are expected to be potential markets with high prevalence of infectious diseases, development of healthcare infrastructure, aging of population resulting in rising incidencesof cardiac diseases, increasing government initiatives to boost the biotechnology industry in the respective countries and rapidly increasing awareness about disease diagnosis and prevention.



Browse the full Life Science Reagents Market report at http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html


The global life science reagents market is characterized by the presence of a largenumber of market players. The matured market players intensively follow predatory business strategies such as acquisition of small market entrants with breakthrough technologies. Some of the key participants operating in this market includeAbbott laboratories, Agilent Technologies, bioMerieux, Life Technologies Corporation, Bio-Rad Laboratories, Inc., GE Healthcare, Merck Millipore, Sigma Aldrich Corporation and Lonza Group Ltd.



The global life science reagentsmarket is segmented as follows:
Life Science Reagents Market, by Product Type
Polymerase chain reaction (PCR) reagent kits
Cell and tissue culture reagents
Flow cytometry reagents
Electrophoresis reagents
Chromatography reagents
In-vitro diagnostic (IVD) reagents
Others
Life Science Reagents Market, by End User
Commercial and contract manufacturers
Research and academic institutions
Clinical laboratories
Forensic laboratories
Life Science Reagents Market, by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)



Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1162



About Us



Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.



Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.



Contact:
Mr.Nachiket
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Organ Preservation Solutions Market predicted to reach USD 204.9 Million Globally in the Forecast 2013 - 2019

Transparency Market Research announced its new report on the Organ Preservation Solutions market that was first valued at USD 0.06 billion in 2012. However, the current market value is predicted to reach USD 204.9 million by 2019 at a CAGR growth rate of 16.5% for the market revenue forecast period 2013 to 2019.


Browse Full Report Organ Preservation Solutions Market Research Report With Full TOC @ http://www.transparencymarketresearch.com/organ-preservation-solutions.html


An organ preservation solution is a method of preserving the organs of the body when they are not inside the body system. It is a medically proven technique of letting the organs become vulnerable to the exterior environment outside the human body. Hence, the organs that are removed from the human body are then preserved in specific adjustments using medical solutions. Organ preservation solutions have been playing a key role in increasing the number of organ transplants. They are intended for different purposes such as organ development of biologics and drugs, and organ transplant procedures and research.

Today, the medical industry has a growing demand for organ transplants in forms of different organ types including liver and kidney too. Such aspects are likely to infuse significant demand for organ preservation solutions in the long run.


The global market for organ preservation solutions has been predicted to grow at a CAGR rate of 16.5% during the forecast period 2013 to 2019. Moreover, it is projected to reach market revenue of USD 204.9 Million in the same forecast period. The Organ preservation solutions report studies the deep insights of this market and foresights every major solution for preserving organs. Amongst the proposed solutions, Viaspan and Custodiol are together accounted for over 75% of the total market share. During this market forecast period 2013 to 2019, the Custodiol market is predicted to rise and grow at a CAGR of 17.1%.

The organ preservation solutions market is primarily driven by the rising incidences of organ failures in the patients due to changes in lifestyles such as fast food consumption, smoking, and alcohol, and increasing number of patients who are eagerly waiting to get an organ transplant done. The market also gets its popularity due to the rise in geriatric population, particularly in the developed regions such as U.K and U.S. All these conditions and locales are likely to propel the growth of this specific market. Another major reason for this growing sector is the rise in per capita healthcare expense and the advancing imbursement setups arranged for the organ transplant procedures in nations such as U.K, U.S., as well as now in India too.

Additionally, there are interesting techniques which are implemented to preserve the organs in the appropriate spaces. These include hypothermic perfusion preservation (HPP), static cold storage (SCS), and many others. Organ preservation solutions is extensively utilized for preserving different organs such as liver and kidney as it is highly capable of preserving a variety of organs unlike solutions such as HBS and Perfadex solution.

Unlike the SCS that does not allow any continuous contact of the organ with solution, the HPP is a much better and adaptable technique to use. It is a machine perfusion process that maintains a constant supply to the organs needed by the solution whereby, the survival duration of the organs increases accordingly. The HPP market is anticipated to grow at a CAGR of 19.2% during the forecast period 2013 to 2019.

Earlier, in 2012, the European region had been accounted for the largest share of market revenue and until the present times, it still continues to prove its growth with a rate of 49.96% for 2012 (%). This is due to the presence of a large number of voluntary organ donors in this region. Nevertheless, other countries such as North America (42.23%), Asia-Pacific (5.66%), and RoW (2.15%) help propel the growth of the organ preservation solutions market as well.

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1786

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Non-Invasive Prenatal Testing (NIPT) Market Expected to Reach USD 1.97 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Non-Invasive Prenatal Testing (NIPT) Market - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 - 2020,” the global NIPT market was valued at USD 0.53 billion in 2013 and is expected to grow at a CAGR of 19.8% from 2014 to 2020, to reach an estimated value of USD 1.97 billion in 2020.

Over the past two years, the global prenatal testing market is witnessing a paradigm shift towards the growing demand for non-invasive prenatal testing over the conventional prenatal screening and diagnostic methods such as maternal serum screening, nuchal translucency (NT) scan, amniocentesis and chorionic villus sampling (CVS). It is mainly because of advantages associated with NIPTs such as safety, accuracy, and no risk of miscarriage during the genetic screening test for the common chromosomal abnormalities (trisomy 21, trisomy 18, trisomy 13, monosomy X, etc.).


BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT are the commercially available NIPTs in the global market which are based on the direct analysis of cell-free fetal DNA in the maternal blood. MaterniT21 (MaterniT21 PLUS) was the first non-invasive prenatal Laboratory Developed Test (LDT) that was launched by Sequenom, Inc. in October 2011 for detection of trisomy 21. MaterniT21 PLUS gained advantage of being the first mover in the competitive landscape of NIPT market and was the most accepted NIPT in 2013, accounting for 36.1% share of the global NIPT market revenue. During the forecast period from 2014 to 2020, its share is likely to decrease significantly due to increasing market penetration by other aforementioned NIPTs such as NIFTY, Panorama and verifi.


Advantages offered by NIPT such as non-invasive nature, high accuracy and early detection, rising awareness, increasing market penetration in the highly untapped European and Asian countries, and continuous increase in average maternal age have been identified as the major factors that are expected to drive growth of the global NIPT market during the forecast period. However, the market may face significant challenges from ethical and regulatory hurdles associated with the implementation of NIPT on account of the belief that it is likely to increase the incidence of abortions. As a consequence, various professional organizations such as the American College of Obstetricians and Gynecologists (ACOG), International Society for Prenatal Diagnosis and The Japan Society of Obstetrics and Gynecology, and genetic counselors around the world have set up guidelines that limit the use of non-invasive prenatal testing only to pregnant women at high risk of chromosomal aneuploidies.

Geographically, North America was the largest regional market in 2013 with a market share of 58.8% of the total revenue generated globally, followed by Europe. Sequenom, Inc., Illumina, Inc., Ariosa Diagnostics, Inc., Natera, Inc. and LabCorp are the major players operating in the North American market. The fact that first non-invasive prenatal test, MaterniT21 (Sequenom, Inc.) was launched in the U.S. and the major four players operating in the NIPT market are domiciled in the U.S. are among the major factors responsible for North America dominating the global NIPT market in 2013. The increasing penetration by test developers in European, Asia-Pacific and Middle-East countries indicates promising growth in the near future in these markets. Sequenom, Inc., Illumina, Inc. (Verinata Health, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Diagnostics, LifeCodexx AG, LabCorp and Berry Genomics are the companies engaged in providing non-invasive prenatal tests worldwide.


Browse the full Non-Invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, informaSeq, MaterniT21 PLUS, NIFTY, Panorama, PrenaTest, verifi and VisibiliT) - Global Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html


The global non-invasive prenatal testing market is segmented as follows:
SNon-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Test
BambniTest
Harmony
informaSeq
MaterniT21 PLUS
NIFTY
Panorama
PrenaTest
verifi
VisibiliT
Non-Invasive Prenatal Testing Market Revenue (USD Million) and Volume (Number of Tests Performed), by Geography
North America
Europe
Asia-Pacific
Rest of the World (RoW)

Request a Sample of this Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374



About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.


Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Aptamers Market Expected to Reach USD 4.33 Billion Globally in 2019

According to a new market report published by Transparency Market Research Aptamers Market (By Types - Nucleic Acid Aptamers and Peptide Aptamers; By Applications - Therapeutics Development, Diagnostics, Research and Development Applications and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019, the global aptamers market was valued at USD 93.0 million in 2012 and is estimated to reach USD 4,333.0 million in 2019, growing at a CAGR of 73.1% from 2013 to 2019.

Aptamers are single-stranded nucleic acid oligonucleotide or peptide molecules. Aptamers can bind with a range of target molecules such as proteins, carbohydrates, ions and viruses. Aptamer technology is widely used in laboratory diagnosis, molecular recognition, pharmaceutical studies, drug discovery and disease treatment. Moreover, these play an important role in the production of improved and cost-effective medicines. Increasing scientific research activities in aptamer technology and rising participation of private organizations for the development of aptamers would boost the growth of the aptamers market globally. Furthermore, collaboration of key players to develop innovative aptamer technologies would drive market growth. For example, Aptamer Group focuses on collaborating with government agencies and academic partners for the development of effective and innovative aptamer technologies. These collaborations would establish a healthy platform for the development of aptamers, which in turn would accelerate market growth. However, strict regulations and ethical issues related to aptamers would restrain the growth of the market.

The aptamers market is segmented by types and by applications. The aptamers market by types is segmented into nucleic acid aptamers and peptide aptamers. The nucleic acid aptamers segment accounted for the largest share of the aptamers market in 2012. It is expected to dominate the market during the forecast period. Growth in this segment is attributed to increasing use of nucleic acid aptamers in research and development. Additionally, nucleic acid aptamers is projected to be the fastest growing segment during the forecast period. The aptamers market, by application is segmented into therapeutics development, diagnostics, research and development applications and others. The diagnostics application segment is likely to grow consistently due to increasing use of aptamers in biomedical diagnostics, molecular imaging and development of disease related biomarkers. However, the therapeutics development application segment is estimated to grow at the highest CAGR due to increasing research and development activities in aptamer technology to develop novel therapeutic agents.

North America accounted for the largest share of the global aptamers market in 2012. Presence of a large number of key players and increasing research and development activities in aptamer technology in North America are the major factors contributing to the growth of aptamers market. Europe accounted for the second largest share i.e., over 35% of the total market in 2012. The aptamers market is majorly driven by increasing use of aptamer technologies by small-scale industries in Europe. Asia-Pacific is expected to grow at the highest CAGR from 2013 to 2019 due to increasing initiatives undertaken by governments for the development of aptamers. There is intense competition in the global aptamers market. Manufacturers are increasing their investment in aptamer technology. The global aptamers market includes major companies such as Somalogic, Inc., NOXXAN Pharma AG, Aptamer Science, Inc. and Aptagen, Inc.

Browse the full Aptamers Market report at http://www.transparencymarketresearch.com/aptamers-market.html

The global aptamers market is segmented into the following categories:
Aptamers Market, by Types
Nucleic Acid Aptamers
Peptide Aptamers
Aptamers Market, by Applications
Therapeutics Development
Diagnostics
Research and Development Application
Others
Aptamers Market, by Geography
North America
Europe
Asia-Pacific
Rest of World (RoW)

Request a Sample of this Report :http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1335


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

The Global Synthetic Biology Market to Reach US$13,375.5 Million by 2019

The synthetic biology market has registered a massive growth in current times, owing to the rise in demand for bio-based chemicals, renewable fuels, and inexpensive drugs and vaccines, which use synthetic biology techniques and products. The global synthetic biology market was worth US$1,769.8 million in 2012. By 2019, it is likely to reach US$13,375.5 million, growing at 32.6% CAGR of from 2013 to 2019.

Synthetic biology is defined as the synthesis of natural or artificial components with the purpose of forming a new artificial living system by restyling current biological elements. It targets to attain preferred utilities of artificially customized organisms, which are intended for high yield biological systems production. Synthetic biology plays a significant role in the area of life sciences by producing cheap synthesis procedures. Growing scientific research added with introduction of highly developed techniques in synthetic biology will boost the growth of synthetic biology market.

Analyzing the Synthetic Biology Market

The global synthetic biology market is analyzed on four fronts: Product, application, technology, and geography.

Synthetic biology market, based on products, is divided into core products and enabling products. Core products include XNA, synthetic DNA, synthetic cells, synthetic genes, and chassis organisms. This market was led by synthetic DNA in 2012 due to the commercial availability of this product compared to other synthetic core products, which are likely to be launched in the market in near future. Enabling product is considered as the fastest developing category, growing at 53.7% CAGR from 2013 to 2019.

Based on application, synthetic biology market is classified into agriculture, chemicals, and healthcare. Healthcare was the largest revenue making category in 2013. It is expected that this category would maintain its dominance on the other categories of synthetic biology market in revenue generation.

According to technology, synthetic biology market is categorized into DNA sequencing, genome engineering, bioinformatics, and biological components and integrated systems. Genome engineering technology can be utilized in transforming gene cloning, genetic foods, and gene therapy.

Geographically, synthetic biology market is divided into North America, Europe, Asia Pacific and Rest of the World. Europe accounted for the largest revenue generation in 2013, and it is expected to continue its dominance on the other categories in revenue generation. Supportive government regulations in Europe made it possible to invest a lot in the synthetic biology research. Asia Pacific is the fastest developing segment with 46.4% CAGR during 2013 to 2019.

Request a Sample of this Report:http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=421

Synthetic Biology Market - Growth Drivers

The factors that are propelling the growth of the synthetic biology market is the population base suffering from malnutrition, which brings in the requirement for increased food production. This factor eventually results in increased demand for synthetically transformed crops. Increasing petroleum based fuel costs are resulting in growing demand for bio-diesel, which is also adding to the growth of the synthetic biology market.

Major Players of Synthetic Biology Market

Thermo Fisher Scientific, Inc., DuPont, Inc., Green Biologics Limited, Bayer AG, REG Life Sciences, LLC, GeneScript Corporation, Amyris, Inc., Genomatica, Inc., ATG:biosynthetics GmbH, Algenol Biofuels, Inc., OriGene Technologies, Inc., New England Biolabs, Inc., Cobalt Technologies, Gevo, Inc., Ginkgo Bioworks, Agrivida, Inc., Bioneer Corporation, Exxon Mobil Corporation, Royal DSM, Biosearch Technologies, Inc., GeneWorks Pty Ltd., Bristol-Myers Squibb, Evolva SA, and CBC Comprehensive Biomarker Center GmbH are the key players of the synthetic biology market.

Many of synthetic biology applications have entered the commercial market as of now and many are on the verge of commercialization in near future. The detailed information and insight of the synthetic biology market will give an advantage to the shareholders as the market is showing excellent possibilities for future.

Browse Full Global Synthetic Biology Market Report With Complete TOC @ http://www.transparencymarketresearch.com/synthetic-biology-market.html

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Array Instruments Market Expected to Reach USD 1.12 Billion Globally in 2020

According to a new market report published by Transparency Market Research “Array Instruments Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020,” the global array instruments market was valued at USD 0.87 billion in 2014 and is expected to grow at a CAGR of 4.3% from 2014 to 2020, to reach an estimated value of USD 1.12 billion in 2020.


The microarray industry continues to shift focus from research and development tools towards different applications in various areas such as drug discovery, clinical diagnostics, and sequencing. Major applications of the technology lie in gene expression, cancer diagnosis and treatment, SNP genotyping, genomics, agricultural biotechnology, drug discovery, and proteomics. In future advances in microarray technology helping in disease diagnosis and drug response are expected to have a high impact on the market growth. Microarrays have also been successfully applied in a variety of other areas such as toxicogneomics, environmental sciences, biodefense, agriculture research, veterinary and forensics.

global-array-instruments-market

The global array instruments market can be categorized into technologies, end-users and geography. DNA microarray is the prime and traditional microarray technology. Availability of a wide range of instruments for DNA microarray analysis and their efficacy in both research and drug discovery are the major factors driving the demand for microarray instruments. DNA microarray technology accounts for around 50% of the total array instruments market. It is expected that the global market for DNA microarray will grow at a CAGR of 3.9% from 2014 to 2019.

Technological advancements in fluorescent labeling and detection methods have offered significant advantage in data, quality, speed, and user safety for microarray based assays. This has enabled microarray based genomic technologies to revolutionize genetic analysis of biologic systems and the widespread routine use of these genomic technologies. Disease diagnosis and identification and research and drug discovery are the two prime application areas of microarray instruments. Thus in terms of end-users, research and development segment is expected to dominate the global array instruments market during the given period of forecast. Use of CytoScanHD microarray technology designed by Affymetrix has helped in searching millions of chromosomes and unique pattern in the cancer cells of leukemia patients. This new approach may be a sign of new revolution in diagnosis and treatment of cancer. Lack of efficient data analysis tools and the lack of expertise in microarray coupled with expensive nature of technology, is expected to be a significant restraint until local entities do not introduce similar technologies at lower cost.

Geographically, North America is the dominant regional market for array instruments with almost half of the market share, followed by Europe accounting for around 30% share. The array instrument market in North America was valued at USD 417.4 million in 2014 and is expected to reach USD 526.4 million by 2020. Emerging countries of Asia-Pacific, Latin America and Middle-East are expected to undergo rapid market growth by 2020. Improvement in healthcare infrastructure and growing preference for safer and easier targeted therapies are the major factors which will fuel market growth in these regions. Identification of genomic differences to predict drug resistance or drug response by patients may offer scope to design a customized therapy tailored to the specific characteristics of a particular cancer. Further exploration in the field of microarray analysis may also assist in developing preventive, regenerative and personalized and targeted therapy for other difficult-to-treat diseases of the central nervous system and vital organs.

Recent studies have demonstrated success of glycan arrays for high throughput elucidation of interactions between different carbohydrates and biological targets, such as proteins, viruses, cells and antibodies. One of the major advantages associated with glycan array analysis compared to traditional methods is multivalent display of arrayed glycans mimicking the real cell surface display. The array instruments market is highly fragmented and consists of many large and small players. The competition in this market is characterized by market consolidation activities, partnerships and intensive mergers and acquisitions. Microarray technology is dominated by few major players such as Affymetrix, Inc. Illumina, Inc., Agilent Technologies and Molecular Devices contributing to around 80% of the total market. Other players in the array instruments market include Bio-Rad Laboratories, Thermo Fischer Scientific, ArrayJet Ltd and Sigma Aldrich Corporation.


Browse the full Array Instruments Market (Technologies: DNA Microarrays, Protein Microarrays, Cellular Microarrays, Tissue Microarrays; End Users: Research and Development Laboratories, Clinical Diagnostic Labs, Agriculture Research Centers, Forensic Centers, Veterinary Laboratories) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 report at http://www.transparencymarketresearch.com/global-array-market.html


The global array instruments market is segmented as follows:

Array Instruments Market, by Technology
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Array Instruments Market, by End-Users
Research and Development Laboratories
Clinical Diagnostic Labs
Agriculture Research Centers
Veterinary Laboratories
Forensic Centers
Array Instruments Market, by Geography
North America
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Europe
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Asia-Pacific
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays
Rest of the World (RoW)
DNA Microarrays
Protein Microarrays
Cellular Microarrays
Tissue Microarrays

Request a Sample of this Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=495


About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.